The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 73-80

  Velázquez Sánchez, Clara ^a   García Verdugo, José M ^b   Murga, Juan ^c   Canales, Juan J ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITAT JAUME I   (Spain)

Author keywords

Amphetamine; Asymmetric synapses; Benztropine analog; Dendritic spines; Nucleus accumbens; Sensitization

Indexed keywords

[N (N BUTYL) 3ALPHA [BIS(4' FLUOROPHENYL)METHOXY]TROPANE]; AMPHETAMINE; DOPAMINE UPTAKE INHIBITOR; JWH 007; PLACEBO; UNCLASSIFIED DRUG;

AMPHETAMINE DEPENDENCE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; DENDRITIC SPINE; DRUG DEPENDENCE; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; EXPERIMENTAL MOUSE; LOCOMOTION; MALE; MOUSE; NERVE CELL PLASTICITY; NERVE STIMULATION; NEUROANATOMY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PSYCHOMOTOR ACTIVITY; SENSITIZATION; SYNAPTIC TRANSMISSION;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BENZTROPINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; SILVER STAINING;

EID: 84874371889     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.016     Document Type: Article

References (58)

1. Agoston G.E., Wu J.H., Izenwasser S., George C., Katz J., Kline R.H., et al. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. J Med Chem 1997, 40:4329-4339.
2. Alcantara-Gonzalez F., Juarez I., Solis O., Martinez-Tellez I., Camacho-Abrego I., Masliah E., et al. Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration. Synapse 2010, 64:786-793.
3. Alfaro-Cervelló C., Soriano-Navarro M., Gomez-Pinedo U., Garcia-Verdugo J.M. Correlation of light and electron microscopy for immunogold staining. GFP immunogold, tool in biological research. Microsc Sci Technol Appl Educ 2011, 844-850.
4. Crombag H.S., Gorny G., Li Y., Kolb B., Robinson T.E. Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 2005, 15:341-348.
5. Desai R.I., Kopajtic T.A., Koffarnus M., Newman A.H., Katz J.L. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 2005, 25:1889-1893.
6. Ferragud A., Velazquez-Sanchez C., Hernandez-Rabaza V., Nacher A., Merino V., Carda M., et al. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat. Psychopharmacology (Berl) 2009, 207:281-289.
7. Gorelick D.A., Gardner E.L., Xi Z.X. Agents in development for the management of cocaine abuse. Drugs 2004, 64:1547-1573.
8. Greenough W.T. Structural correlates of information storage in the mammalian brain: a review and hypothesis. Trends Neurosci 1984, 7:229-233.
9. Greenough W.T., Bailey C.H. The anatomy of a memory: convergence of results across a diversity of tests. Trends Neurosci 1988, 11:142-147.
10. Greenough W.T., Withers G.S., Wallace C.S. Morphological changes in the nervous system arising from behavioural experience: what is the evidence that they are involved in learning and memory? 1990, 159-185. Schattauder, New York. L.R. Squire, E. Lindenlaub (Eds.).
11. Guirado R., Varea E., Castillo-Gomez E., Gomez-Climent M.A., Rovira-Esteban L., Blasco-Ibanez J.M., et al. Effects of chronic fluoxetine treatment on the rat somatosensory cortex: activation and induction of neuronal structural plasticity. Neurosci Lett 2009, 457:12-15.
12. Harris K.M., Kater S.B. Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 1994, 17:341-371.
13. Hiranita T., Soto P.L., Newman A.H., Katz J.L. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 2009, 329:677-686.
14. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991, 16:223-244.
15. Katz J.L., Libby T.A., Kopajtic T., Husbands S.M., Newman A.H. Behavioral effects of rimcazole analogues alone and in combination with cocaine. Eur J Pharmacol 2003, 468:109-119.
16. Katz J.L., Kopajtic T.A., Agoston G.E., Newman A.H. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 2004, 309:650-660.
17. Kim Y., Teylan M.A., Baron M., Sands A., Nairn A.C., Greengard P. Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbens. Proc Natl Acad Sci U S A 2009, 106:2915-2920.
18. Kolb B., Forgie M., Gibb R., Gorny G., Rowntree S. Age, experience and the changing brain. Neurosci Biobehav Rev 1998, 22:143-159.
19. Kolb B., Gorny G., Li Y., Samaha A.N., Robinson T.E. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci U S A 2003, 100:10523-10528.
20. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 1988, 242:715-723.
21. Kopajtic T.A., Liu Y., Surratt C.K., Donovan D.M., Newman A.H., Katz J.L. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability. J Pharmacol Exp Ther 2010, 335(3):703-1.
22. Lawrence R.C., Otero N.K., Kelly S.J. Selective effects of perinatal ethanol exposure in medial prefrontal cortex and nucleus accumbens. Neurotoxicol Teratol 2012, 34(1):128-135.
23. Li Y., Kolb B., Robinson T.E. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 2003, 28:1082-1085.
24. Martin B.J., Naughton B.J., Thirtamara-Rajamani K., Yoon D.J., Han D.D., Devries A.C., et al. Dopamine transporter inhibition is necessary for cocaine-induced increases in dendritic spine density in the nucleus accumbens. Synapse 2011, 65:490-496.
25. Martinez-Tellez R.I., Hernandez-Torres E., Gamboa C., Flores G. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 2009, 63:794-804.
26. Moro H., Sato H., Ida I., Oshima A., Sakurai N., Shihara N., et al. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Pharmacol Biochem Behav 2007, 87:56-64.
27. Morshedi M.M., Meredith G.E. Differential laminar effects of amphetamine on prefrontal parvalbumin interneurons. Neuroscience 2007, 149:617-624.
28. Morshedi M.M., Rademacher D.J., Meredith G.E. Increased synapses in the medial prefrontal cortex are associated with repeated amphetamine administration. Synapse 2009, 63:126-135.
29. Newman A.H., Kulkarni S. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic-a focus on analogues of benztropine and rimcazole. Med Res Rev 2002, 22:429-464.
30. Newman A.H., Allen A.C., Izenwasser S., Katz J.L. Novel 3 alpha-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 1994, 37:2258-2261.
31. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl) 1991, 103:480-492.
32. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
33. Podet A., Lee M.J., Swann A.C., Dafny N. Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Res Bull 2010, 82:293-301.
34. Purves D. Neural activity and the growth of the brain 1994, Cambrige UP., Cambridge, U.K.
35. Raje S., Cao J., Newman A.H., Gao H., Eddington N.D. Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 2003, 307:801-808.
36. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
37. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
38. Robinson T.E., Berridge K.C. Addiction. Annu Rev Psychol 2003, 54:25-53.
39. Robinson T.E., Camp D.M. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol Biochem Behav 1987, 26:821-827.
40. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997, 17:8491-8497.
41. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 1999, 11:1598-1604.
42. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl. 1):33-46.
43. Robinson T.E., Gorny G., Mitton E., Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001, 39:257-266.
44. Rothman R.B. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci 1990, 46:L17-L21.
45. Rothman R.B., Baumann M.H., Prisinzano T.E., Newman A.H. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol 2008, 75:2-16.
46. Segal D.S., Geyer M.A., Schuckit M.A. Stimulant-induced psychosis: an evaluation of animal methods. Essays Neurochem Neuropharmacol 1981, 5:95-129.
47. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 1953, 87:387-406.
48. Shuto T., Kuroiwa M., Hamamura M., Yabuuchi K., Shimazoe T., Watanabe S., et al. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist. Neuropharmacology 2006, 50:991-997.
49. Shuto T., Seeman P., Kuroiwa M., Nishi A. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats. Eur J Neurosci 2008, 27:2551-2557.
50. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993, 4:289-312.
51. Tanda G., Newman A.H., Ebbs A.L., Tronci V., Green J.L., Tallarida R.J., et al. Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. J Pharmacol Exp Ther 2009, 330:802-809.
52. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151:99-120.
53. Velazquez-Sanchez C., Ferragud A., Hernandez-Rabaza V., Nacher A., Merino V., Carda M., et al. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. Neuropsychopharmacology 2009, 34:2497-2507.
54. Velazquez-Sanchez C., Ferragud A., Murga J., Carda M., Canales J.J. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization. Eur Neuropsychopharmacol 2010, 20:501-508.
55. Velazquez-Sanchez C., Ferragud A., Renau-Piqueras J., Canales J.J. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction. Int J Neuropsychopharmacol 2010, 1-11.
56. Velázquez-Sánchez C., Ferragud A., Ramos-Miguel A., García-Sevilla J.A., Canales J.J. Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking. Addict Biol 2012, 10.1111/j.1369-1600.2012.00458.x.
57. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 1987, 94:469-492.
58. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998, 54:679-720.